Current Location: School> English> Faculty> Deparment of Pharmacy Administration and Clinical Pharmacy

Nie Xiaoyan

niexiaoyan.jpg

  

Nie Xiaoyan

Associate Researcher

Research AreasPersonalized/Precision Medicine and Pharmacogenetics, Pharmacy Practice Intervention Evaluation and Pricing, Education and Practice System of Clinical Pharmacy

Tel: +86-010-82805880

Email: niexy@pku.edu.cn


EDUCATION

Doctor of Philosophy, Peking University (2017)

Master of Science, Peking University (2008)

Bachelor of Science, Peking University (2006)

 

ACADEMIC APPOINTMENTS

2025-present Associate researcher, Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutics Sciences, Peking University

2019-present Associate director of Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutics Sciences, Peking University Health Science Center

2019-present  Senior Researcher, International Research Centre of Medicinal Administration (IRCMA), Peking University

2008-2025 Assistant professor, lecturer, Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutics Sciences, Peking University

2020-2021 Visiting Scholar, Research Fellow, Harvard Medical School 

 

PROFESSIONAL AFFILIATIONS

2025-present, International Pharmaceutical Federation Hospital Pharmacy Section Global Advisory Group (FIP-GAG), Expert

2025-present, Pharmacogenomics Research Network Global Committee, Expert

2022-present, Chinese Research Hospital Association, Pharmacoeconomics Professional Committee, Committee member,

2021-present, Quantitative Pharmacology Professional Committee, Chinese Pharmacological Society, Committee member


AWARDS AND CERTIFICATES


Peking University Model Course on Curriculum Ideology and Politics (2022)

First Prize of Peking University Teaching Achievements (2025)

Second Prize of Beijing Science and Technology Progress Award (2023)

Outstanding Teacher, Peking University Health Science Center (2009, 2010)

Third prize for young teachers' teaching skills competition, Peking University (2017)


REPRESENTATIVE PUBLICATIONS

1. Xinyan Zhang, Jie Li,Ning Zhang,Tiebang Liu,Tianmei Si, Xiaoyan Nie*, Luwen Shi. Prevalence and characteristics of off-label use of antidepressants in paediatric patients in China. General Psychiatry. 2025;38:e102229. doi:10.1136/ gpsych-2025-102229.(IF=7.0,Q1)

2. Zinan Zhao, Yuxuan Zhao, Xiaowen Hu, Xue Wang, Gengchen Wang, Xinyi Zhang, Wenliang Dong, Luwen Shi, Xiaodong Guan, Christine Y. Lu, Pengfei Jin, Xiaoyan Nie*. (2025), Use of Drugs With Actionable Pharmacogenetic Biomarkers and Possible Prescribing Changes Among Older People.Journal of the American Geriatrics Society, 2025; 0:1–11. https://doi.org/10.1111/jgs.70126.(IF=4.5,Q1)

3. Xinyan Zhang, Xiaoyan Nie*, Luwen Shi. Treatment indications for antidepressants prescribed in primary health care facilities in Beijing, China. International Psychogeriatrics. 2025 Aug;37(4):100057. doi: 10.1016/j.inpsyc.2025.100057. Epub 2025 Mar 12. PMID: 40074596.(IF=4.3,Q1)

4. Ziyan Ding, Hui Zhang, Fan Huang, Yian Liu, Qian Zhou,  Dingyuan Hu1, Liming Chen, Yanting Li,  Rui Ding, Xiaoyan Nie*,  Yi Fang*. Efficacy and Safety of Biologics for Systemic Lupus Erythematosus (SLE): A Systematic Review and Network Meta‐Analysis. Clinical Reviews in Allergy & Immunology, 2025 July, 68:70 https://doi.org/10.1007/s12016-025-09082-x. (IF=11.3,Q1)

5. Caiying Wu,Gengchen Wang,Xiaowen Hu, Shiyu Zhang, Xindi Liu, Xue Wang, Jingtao Liu, Wei Liu, Xu Ma, Xiaoyan Nie,*Xiaodong Guan.Discordances between molecular profiling and precision oncology drug selection of non-small cell lung cancer in China. The Lancet Regional Health - Western Pacific 2025;55S1: 101451.(Abstract) (IF=8.1,Q1)

6. Fan Huang, Dingyuan Hu, Huaying Fan, Binyi Hu, Yian Liu, Wenliang Dong, Xiangxing Liu, Yanting Li, Diqin Yan, Rui Ding, Suping Niu, Liming Chen*, Xiaoyan Nie*, and Yi Fang*.Efficacy and Safety of Janus Kinase Inhibitors in Patients with Vitiligo: A Systematic Review and Meta-Analysis. Clinical Pharmacology & Therapeutics. 2025 Mar;117(3):659-669. doi: 10.1002/cpt.3538. Epub 2024 Dec 23.(IF=5.5,Q1)

7. Xinyi Zhang, Yuchun Cai, Pei Zhou, Wenchang Nie, Haoning Sun, Yutong Sun, Yuxuan Zhao,  Congxiao Han, Chengfu Cao, Jian Liu,  Xiaoyan Nie, Pharmacogenomic Polygenic Model of Clopidogrel Predicts Recurrent Ischemic Events in Chinese Patients With Coronary Artery Disease. Clinical Therapeutics. 2024 Aug;46(8):644-649. doi: 10.1016/j.clinthera.2024.06.019. Epub 2024 Jul 26.(IF=3.6,Q2)

8. Xinyan Zhang#, Xiaowen Hu#, Christine Y Lu, Xiaoyan Nie*, Luwen Shi.Trends in prescription of psychotropic medications to children in China from 2013 to 2016.Asian Journal of Psychiatry. 2023, April. Vol. 57(5) 767–769. (IF=13.890, Q1)

9. Xiaoyan Nie, Ruilin Wang , Guangkai Liang, Xinyi Zhang, Ningjia Tang, Yuchun Cai, Congxiao Han, Y (Iuxuan Zhao, Tong Jia, Fang Zhang , Sheng Han , Xiaodong Guan , Luwen Shi , Christine Y Lu . The Impact of Prescribing Monitoring Policy on Drug Use and Expenditures in China: A Multi-center Interrupted Time Series Study. International Journal of Health and Policy Management. 2023:12:7343. doi: 10.34172/ijhpm.2023.7343. Epub 2023 Jun 20.(IF=5.0, Q1)

10. Wenliang Dong, Xiaowen Hu, Caiying Wu, Gengchen Wang, Yi Fang*, Luwen Shi*, Xiaoyan Nie*. Efficacy, safety, and cost-effectiveness of therapeutic drug monitoring (TDM) for TNF inhibitor therapy in rheumatic disease: A systematic review and meta-analysis. Seminars in Arthritis and Rheumatism. 2023 Dec;63:152302. doi: 10.1016/j.semarthrit.2023.152302. Epub 2023 Nov 4. (IF=4.4, Q1)

11. Xinyan Zhang, Xiaowen Hu, Yuchun Cai, Christine Y Lu, Xiaoyan Nie*,Luwen Shi. Antidepressants utilization in Mainland China: Based on the National Health Insurance Database. Australian & New Zealand Journal of Psychiatry. 2023 May;57(5):767-769. doi: 10.1177/00048674221144421..(IF=3.7, Q1)

12. Xiaoyan Nie Tong Jia, Xiaowen Hu, Sicong Li, Xinyi Zhang, Caiying Wu, Yuqing Zhang, Jing Chen, Luwen Shi, Christine Y Lu.Clinical Pharmacists' Knowledge of and Attitudes toward Pharmacogenomic Testing in China. Journal of personalized medicine. 2022 Aug 21;12(8):1348. doi: 10.3390/jpm12081348.(IF=3.0, Q2)

13. Xiaowen Hu, Tong Jia, Xinyi Zhang, Caiying Wu, Yuqing Zhang, Jing Chen, Xiaodong Guan, Luwen Shi, Christine Y Lu , Xiaoyan Nie* .Clinical Pharmacists' Involvement in Pharmacogenomics Testing and Related Services in China.Journal of personalized medicine. 2022 Jul 31;12(8):1267. doi: 10.3390/jpm12081267. (IF=3.5, Q2)

14. Yuxuan Zhao , Xinyi Zhang , Congxiao Han , Yuchun Cai , Sicong Li, Xiaowen Hu, Caiying Wu, Xiaodong Guan, Christine Lu and Xiaoyan Nie*. Pharmacogenomics of Leukotriene Modifiers: A Systematic Review and Meta-Analysis. Journal of personalized medicine, 2022, 12(7), 1068; https://doi.org/10.3390/jpm12071068.  (IF=3.5, Q2)

15. Xiaoyan Nie, Joanne Sordillo, Alberta Wang, Sharon M. Lutz, Michael McGeachie, Amber Dahlin, Kelan G. Tantisira, Carlos Iribarren, Ann Chen Wu*. Genome-Wide Association Study for Longitudinal Therapeutic Response to Montelukast in Adults with Asthma. American Journal of Respiratory And Critical Care Medicine,2021,203(9)S:A3121. (IF=24.7, Q1)

16. Xinyi Zhang, Sicong Li , Yuxuan Zhao , Ningjia Tang, Tong Jia, Pei Zhou, Jian Liu, Luwen Shi, Christine Y Lu, Xiaoyan Nie*. Genetic variants of PEAR1 and ischemic clinical outcomes in coronary artery disease patients: a systematic review and meta-analysis. Pharmacogenomics. 2021 Jul;22(10):641-648. (IF=2.6, Q3)